DBV Technologies | DBVT - Loan Capital

DBV Technologies reported $0 in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Loan Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 967K
Biomarin Pharmaceutical BMRN:US USD 1.08B 1.17M
Esperion Therapeutics ESPR:US USD 259.9M 412K
Galectin Therapeutics GALT:US USD 29.73M 230K
Halozyme Therapeutics HALO:US USD 1.49B 1.61M
Insmed INSM:US USD 1.15B 347.41M
Intercept Pharmaceuticals ICPT:US USD 223.1M 248K
IONIS PHARMACEUT IONS:US USD 1.18B 66.78M
Ptc Therapeutics PTCT:US USD 1.28B 294.53M
Sarepta Therapeutics SRPT:US USD 1.54B 1.52M
United Therapeutics UTHR:US USD 800M 0
YTE INCY:US USD 30.08M 393K